Biopharma's stock market winners of 2022 revealed

Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.

Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial

Evaluate Search

Rubius Therapeutics

Stock market today: Live updates

Orphan Product Marketing Initiative 2022 - MM+M Awards

Pharmaceutical Executive-03-01-2022

Biotech flotations remain in high demand

Halozyme Therapeutics

VC funding trends in biotechnology

Life Sciences 2023 Year End Review / 2024 Outlook - Gibson Dunn